Evidence map›Paper›PMID 35350595›Full record

ArticleBiomedical signal processing and control2022

Effectiveness evaluation of different feature extraction methods for classification of covid-19 from computed tomography images: A high accuracy classification study.

Farid Al-Areqi, Mehmet Zeki Konyar

Abstract read
In one paragraph

Article in Biomedical signal processing and control, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Farid Al-AreqiDepartment of Biomedical Engineering, Kocaeli University, 41001 Kocaeli, Turkey.
Mehmet Zeki KonyarDepartment of Software Engineering, Kocaeli University, 41001 Kocaeli, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rapid diagnosis of the Covid-19 disease is the best way to prevent infection. In this paper, it is proposed to use machine learning methods to aid diagnoses quickly Covid-19 and focused on effect of several features on classification accuracy. In the proposed method 746 axial computed tomography (CT) images of the lung; 349 Covid-19 (positives) and 397 non-Covid-19 (negative) are used. Gray-level texture, shape and first order statistical features were extracted from the images. The feature vector for model training is constructed with one feature group or combination of more than one group. We then classified with Support Vector Machine, Random Forest, k-nearest neighbor and XGBoost classifier models. The hyperparameter of the models were controlled by the tuning test. Experimental results obtained with 10-fold cross-validation. The results of cross-validation verified with the additionally independent test. The best overall accuracy was 98.65% with first order statistics features classified with XGBoost. In the gray level features, the best individual results given by GLSZM as 81.25%, and the best combination result is with GLDM, GLRLM and GLSZM features as 85.52%. An important finding of this paper is that, for Covid-19 classification, the shape and first order statistics features are more valuable than gray level features. The proposed results compared with the literature studies under some Covid-19 dataset for accuracy, precision, sensitivity and F1-score metrics. Also, the literature studies which used the different Covid-19 dataset were compared with the proposed study. Our results have the significant superiority when compared with the literature studies.

Indexed as

Covid-19CT imagesDiagnosisFeaturesMachine learning

Identifiers

PMID35350595
PMCPMC8947946

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.